Semaglutide has emerged as a promising treatment for insulin resistance. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to produce more insulin and reducing glucagon https://hamzahcklt258134.blogerus.com/57718792/grasping-semaglutide-a-comprehensive-guide